Specify a stock or a cryptocurrency in the search bar to get a summary
Nemaura Medical Inc
NMRDNemaura Medical Inc., a medical technology company, manufactures continuous glucose monitoring system in the United States. It offers sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as screen pre-diabetic patients. The company also offers proBEAT, a wellness guidance notes, that provide prompts and educate users on factors affecting blood sugar profiles, as well as conducts diabetes prevention and reversal programs. Nemaura Medical Inc. was founded in 2009 and is based in New York, New York. Address: 57 West 57th Street, New York, NY, United States, 10019
Analytics
WallStreet Target Price
1.5 USDP/E ratio
–Dividend Yield
–Current Year
Last Year
Current Quarter
Last Quarter
Current Year
Last Year
Current Quarter
Last Quarter
Key Figures NMRD
Dividend Analytics NMRD
Dividend growth over 5 years
–Continuous growth
–Payout Ratio 5 years average
–Dividend History NMRD
Stock Valuation NMRD
Financials NMRD
Results | 2019 | Dynamics |